Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.
Heslop
H E
HE
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.
D019264:Adoptive Transfer; D000956:Antigens, Viral / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology; D002460:Cell Line; D020031:Epstein-Barr Virus Infections / Q000517:prevention & control*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D008212:Lymphocyte Depletion; D008232:Lymphoproliferative Disorders / Q000517:prevention & control* / Q000821:virology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000956:Antigens, Viral